MIND & PRACTICE · RESEARCH EXPLAINED

Mindfulness and acceptance:
what does the research show?

Can mindfulness help someone stay well after depression? Can acceptance change how much pain gets in the way of life? The answers depend on what we mean by getting better.

01 · The approaches

Three approaches with different intentions

Imagine two people who both say, “I’d like to feel better.” One has recovered from depression and wants to recognise the early signs of another episode. The other lives with persistent pain and misses having Sunday lunch with family. For the first person, staying well for the next year would be a meaningful result. For the second, being back at that table could matter even on a difficult day. A study that measures only mood today could miss both outcomes.

Research gives us good reasons to take mindfulness and acceptance seriously. Mindfulness-based cognitive therapy has particularly clear evidence for preventing depressive relapse. Structured mindfulness programmes can also reduce anxiety symptoms. Acceptance and commitment therapy can help people do more of what matters to them, with some of its clearest practical applications in persistent pain. The size and certainty of each benefit depend on who took part, what the researchers measured and what the other group received. [1, 3, 5, 6, 7]

Mindfulness-based stress reduction (MBSR)

The course is usually taught over eight weeks. Participants practise directing attention deliberately, for example to sound, movement or bodily sensations. When attention wanders, noticing where it went and choosing to return are part of the exercise. Classes, discussion and regular practice at home make this a substantial commitment. [5]

Mindfulness-based cognitive therapy (MBCT)

This approach combines mindfulness practice with elements of cognitive therapy. Someone who wakes feeling low might quickly arrive at “Here we go again” and spend the morning searching for evidence that they are getting worse. MBCT helps people recognise that familiar sequence early, see the prediction as a thought and draw on a plan for staying well. Researchers call the ability to step back from a thought decentring. [1, 2, 10]

Acceptance and commitment therapy (ACT)

This approach starts with a practical question. When difficult thoughts, feelings or sensations turn up, how much say do they have over what you do next? ACT builds psychological flexibility, the ability to make room for an experience and choose an action guided by personal values. Someone who values friendship might send a message while still feeling apprehensive. Acceptance here concerns the feeling. The person remains free to change their circumstances, set a boundary or seek treatment. [6, 7]

02 · Depressive relapse

Can mindfulness help prevent depression returning?

Kuyken and colleagues pooled individual data from nine randomised trials involving 1,258 adults with a history of recurrent depression. Over 60 weeks, those allocated to MBCT had a lower rate of relapse over time than those allocated to comparison conditions. The hazard ratio was 0.69, with a 95% confidence interval of 0.58 to 0.82. In everyday terms, among people who were still well at a given point during follow-up, the estimated rate of relapse was about 31% lower in the MBCT group. The figure cannot tell us how many people out of 100 would avoid another episode without knowing their starting risk. [1]

When the researchers restricted the comparison to other active treatments, the advantage was smaller, with a hazard ratio of 0.79 (95% confidence interval 0.64 to 0.97). Individual participant data also allowed the team to explore who might benefit most. People with more residual depressive symptoms appeared to gain more, although that finding is too uncertain to predict an individual’s response. [1]

The UK PREVENT trial asked a more specific question. It allocated 424 adults to MBCT with support to taper or discontinue antidepressants, or to continued maintenance antidepressants. Within two years, 94 of 212 people (44%) in the MBCT group and 100 of 212 (47%) in the medication group experienced a relapse or recurrence. The difference was compatible with chance (hazard ratio 0.89, 95% confidence interval 0.67 to 1.18). It was a trial of superiority. Similar observed rates do not establish that the two strategies are interchangeable. [2]

These findings can sit comfortably together. A pooled comparison against several kinds of care can favour MBCT while a direct trial finds no clear advantage over continued medication. NICE includes group MBCT among the relapse-prevention options for adults at higher risk who have improved on antidepressants. The decision takes account of previous episodes, remaining symptoms, preferences and the support available. Anyone considering a medication change should plan it with their prescriber. [1, 2, 9]

03 · Ongoing depression

What if someone is still experiencing depression?

Preventing a future episode and treating ongoing symptoms are separate clinical questions. A 2025 UK trial led by Barnhofer studied adults who remained depressed after a course of high-intensity NHS Talking Therapies treatment. Researchers compared usual care plus MBCT with usual care alone. At 34 weeks, the MBCT group scored an adjusted average of 2.49 points lower on the PHQ-9 depression questionnaire (95% confidence interval 1.09 to 3.89 points lower). Both groups had access to usual care. [4]

That is a modest average advantage in a group for whom earlier therapy had been insufficient. An individual might experience a larger change, little difference or continuing symptoms. The trial gives a clinician a reason to discuss MBCT as a further option in that situation. It leaves open how MBCT would compare with the same amount of another structured therapy. [4]

04 · Anxiety and stress

How much difference does mindfulness make to anxiety and stress?

Goyal and colleagues reviewed 47 randomised trials involving 3,515 participants across meditation programmes. For mindfulness programmes, the estimated benefit for anxiety against non-specific active controls was 0.38 standard deviations at eight weeks and 0.22 at three to six months. For depressive symptoms, the corresponding estimates were 0.30 and 0.23. These are modest average differences. A standardised effect of 0.38 describes the distance between group averages on a common scale. It does not mean that anxiety fell by 38%. [3]

Anxiety and general stress are often used almost interchangeably in conversation. The review found moderate evidence for improvement in anxiety, and weaker evidence for stress or distress as measured in the included studies. It also found insufficient evidence to conclude that meditation programmes outperform established active treatments. [3]

Hoge and colleagues made a direct comparison in 276 adults with diagnosed anxiety disorders. One group received an eight-week MBSR course and the other received escitalopram. Among the 208 participants in the primary per-protocol analysis, clinician-rated severity improved by an average of 1.35 points with MBSR and 1.43 with escitalopram. The difference fell within the trial’s pre-agreed margin for non-inferiority. That design asks whether MBSR could be meaningfully worse than the medication by more than a specified amount. It answered that question favourably at eight weeks. [5]

The practical details matter. Participants attended a taught course and were asked to practise at home. Someone choosing an app, attending an occasional drop-in or wondering whether to change a prescription faces a different decision. The time commitment, personal preference and availability of trained support all affect whether the studied programme is a realistic option. [5]

05 · ACT and CBT

How does ACT compare with other therapies?

A-Tjak and colleagues analysed 39 randomised trials involving 1,821 people with mental or physical health difficulties. Across the main outcomes, the pooled difference favoured ACT by 0.57 standard deviations. The advantage was larger against a waiting list (0.82) and smaller against a psychological placebo, a comparison designed to match some of the experience of receiving help (0.51). Against established cognitive behavioural therapy, the review found no statistically significant difference. [6]

The comparison changes the conclusion. A waiting-list trial can tell us that offering ACT now helped more than asking people to wait. It cannot separate the contribution of acceptance exercises from regular appointments, encouragement or expectations of improvement. Comparing two credible therapies asks a harder question. Here, the evidence supports ACT as a reasonable option across the problems studied, while leaving uncertainty about any advantage over CBT for a particular diagnosis. [6]

06 · Persistent pain

With persistent pain, what counts as improvement?

Think again about Sunday lunch. A pain-intensity scale asks how much it hurts. A pain-interference measure asks how much pain gets in the way of ordinary life. Someone who can share a meal, take breaks and enjoy the conversation may report an important improvement on the second measure while giving much the same answer on the first.

Ye and colleagues reviewed 21 randomised trials of ACT for people with chronic pain. Immediately after treatment, they found medium-sized average benefits for pain interference and functional impairment, and a smaller benefit for pain intensity. This pattern fits the aims of ACT. A person might gain more choice about how to spend their day even when pain remains present. [7]

Confidence depends on the comparison. An earlier Cochrane review judged the ACT evidence against active controls to be very uncertain, owing in part to the small evidence base then available. A larger later review adds information, but pooling studies with different controls cannot by itself settle whether ACT works better than another well-delivered pain programme. NICE advises considering ACT or CBT for pain, delivered by appropriately trained healthcare professionals, for people aged 16 and over with chronic primary pain. That recommendation has a specific scope. [7, 8, 11]

07 · Mechanisms and limits

Why might these approaches help, and who might find them difficult?

Imagine noticing “I’ve ruined the whole week” after one difficult conversation. Recognising this as a familiar thought can create enough space to phone a friend, return to a task or decide whether an apology is needed. A review by Gu and colleagues found evidence consistent with reduced repetitive thinking and changes in how people react to thoughts and emotions as possible routes to benefit in MBCT and MBSR. Measuring two changes together, however, leaves a question about their order. Does less rumination lift mood, or does an improving mood make it easier to disengage? Establishing cause needs repeated measurements and stronger tests. [10]

Acceptability belongs in any discussion of efficacy. Farias and colleagues documented unwanted experiences during or after meditation, including anxiety. Their review covered varied practices and study designs, with widely differing estimates. Those pooled figures cannot give someone their personal risk on a supported eight-week course. If a practice feels overwhelming, it is reasonable to pause and tell the person guiding it. Persistent or worsening distress deserves a conversation with a healthcare professional. [12]

A final limitation cuts across this research. People usually know whether they are attending a group or taking medication, and many outcomes depend on what they report. Independent assessors can reduce some bias. Longer follow-up helps researchers distinguish a useful change during a course from one that lasts. Equally, an average can conceal the experience that matters most to the individual. A symptom score and a question about daily life often tell us more together. [1, 3, 5, 7]

08 · Clinical meaning

What can we reasonably conclude?

For an adult who has recovered from recurrent depression, MBCT has credible evidence as a relapse-prevention option. For someone with an anxiety disorder who is willing and able to undertake a structured course, MBSR has evidence of short-term benefit. For someone whose life has narrowed around persistent pain, ACT offers a way to work towards valued activities, with better evidence for some functional outcomes than for large reductions in pain intensity. Comparisons with established treatments generally support a discussion about choice, preference and access. [1, 3, 5, 6, 7, 11]

A useful question to take into that discussion is “If this approach helped, what would I notice myself doing differently?” The answer might be spotting the early signs of low mood, recovering more quickly after a worry, or staying for dessert. Being clear about that outcome makes the research easier to interpret and the conversation about care more personal.

09 · Reader questions

Frequently asked questions

Do I need to clear my mind to practise mindfulness?

A wandering mind gives you something to notice. In a taught programme, recognising that your attention has drifted and gently choosing where to place it is part of the practice. [5]

Does acceptance mean putting up with pain or a difficult situation?

You can acknowledge what is happening now and still seek medical help, ask for practical changes or set a boundary. In ACT, acceptance helps make room for the action that matters to you. [6, 7]

Can a meditation app deliver the results described here?

The headline trials studied specific programmes, often with a trained teacher, regular sessions and practice at home. An app would need evidence for its own format, population and outcomes. [1, 5]

10 · Further reading

Research and UK guidance

  1. Kuyken et al. (2016)Individual participant data from nine MBCT relapse-prevention trials.
  2. Kuyken et al. (2015) · PREVENTUK trial of MBCT with tapering support and maintenance antidepressants.
  3. Goyal et al. (2014)Systematic review of meditation programmes for psychological stress and wellbeing.
  4. Barnhofer et al. (2025)UK trial of MBCT added to usual care after non-remission following psychological therapy.
  5. Hoge et al. (2023)Randomised comparison of MBSR and escitalopram in adults with anxiety disorders.
  6. A-Tjak et al. (2015)Meta-analysis of ACT for mental and physical health problems.
  7. Ye et al. (2024)Systematic review of ACT for chronic pain, psychological outcomes and quality of life.
  8. Williams et al. (2020) · CochranePsychological therapies for chronic pain in adults, excluding headache.
  9. NICE · NG222 (2022)Depression in adults. See recommendations 1.8.5 and 1.8.6 on preventing relapse.
  10. Gu et al. (2015)Systematic review of proposed mechanisms in MBCT and MBSR.
  11. NICE · NG193 (2021)Chronic primary pain. See recommendation 1.2.3 on ACT or CBT for pain.
  12. Farias et al. (2020)Systematic review of adverse events associated with meditation practices.
CONTINUE READING

Explore the mind a little further

Read more about how the mind responds under pressure.

BEST MIND THERAPY · SWINDON & UK ONLINE

What would you like to feel able to do again?

If you’re considering support, a free consultation with Gary gives you space to talk about what you would like to change and whether his solution focused approach feels right for you.

Enquire about a free consultationGary Smith · Clinical Hypnotherapist & Psychotherapist · Best Mind Therapy Limited